Vaccines, Free Full-Text

Por um escritor misterioso
Last updated 29 setembro 2024
Vaccines, Free Full-Text
The ideal vaccine against viral infections should elicit antibody responses that protect against divergent strains. Designing broadly protective vaccines against SARS-CoV-2 and other divergent viruses requires insight into the specific targets of cross-protective antibodies on the viral surface protein(s). However, unlike therapeutic monoclonal antibodies, the B-cell epitopes of vaccine-induced polyclonal antibody responses remain poorly defined. Here we show that, through the combination of neutralizing antibody functional responses with B-cell epitope mapping, it is possible to identify unique antibody targets associated with neutralization breadth. The polyclonal antibody profiles of SARS-CoV-2 index-strain-vaccinated rabbits that demonstrated a low, intermediate, or high neutralization efficiency of different SARS-CoV-2 variants of concern (VOCs) were distinctly different. Animals with an intermediate and high cross-neutralization of VOCs targeted fewer antigenic sites on the spike protein and targeted one particular epitope, subdomain 1 (SD1), situated outside the receptor binding domain (RBD). Our results indicate that a targeted functional antibody response and an additional focus on non-RBD epitopes could be effective for broad protection against different SARS-CoV-2 variants. We anticipate that the approach taken in this study can be applied to other viral vaccines for identifying future epitopes that confer cross-neutralizing antibody responses, and that our findings will inform a rational vaccine design for SARS-CoV-2.
Vaccines, Free Full-Text
Associations of BMI with COVID-19 vaccine uptake, vaccine
Vaccines, Free Full-Text
Revisiting COVID-19 vaccine hesitancy around the world using data
Vaccines, Free Full-Text
Scent of a vaccine
Vaccines, Free Full-Text
Clinical Resources Archive
Vaccines, Free Full-Text
Covid-19 Vaccinations: County and State Tracker - The New York Times
Vaccines, Free Full-Text
Protection against SARS-CoV-2 after Covid-19 Vaccination and
Vaccines, Free Full-Text
mRNA, the beginning of a new influenza vaccine game
Vaccines, Free Full-Text
Determinants of COVID-19 vaccine acceptance in the US
Vaccines, Free Full-Text
Adverse Effects of Vaccines: Evidence and Causality
Vaccines, Free Full-Text
A Brief History of Vaccination
Vaccines, Free Full-Text
COVID-19 Mobile Vaccination Clinic, City Calendar
Vaccines, Free Full-Text
ASIIS-Web Main Page

© 2014-2024 lexenimomnia.com. All rights reserved.